Tower Research Capital LLC (Trc) Immutep LTD Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Immutep LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 83 shares of IMMP stock, worth $164. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83
Previous 2,689
96.91%
Holding current value
$164
Previous $6,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding IMMP
# of Institutions
35Shares Held
2.41MCall Options Held
526KPut Options Held
222K-
Black Rock Inc. New York, NY839KShares$1.66 Million0.0% of portfolio
-
Meridian Wealth Management, LLC398KShares$788,9310.04% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA248KShares$491,2710.0% of portfolio
-
Jane Street Group, LLC New York, NY126KShares$248,6520.0% of portfolio
-
Old Mission Capital LLC113KShares$223,8130.01% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $172M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...